Edgewise Therapeutics, Inc.

EWTX·NasdaqGS·Healthcare
Compare
38.45−0.61 (−1.56%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
Pre-market38.33−0.12 (−0.31%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close39.06
Open39.12
Day range38.3239.36
52-week range14.2548.51
Off day high−2.31%
Off 52-week high−20.74%
Volume1.47M
Avg. volume (3M)1.35M
Market cap4.18B
EPS (TTM)-1.89
Forward P/E-21.17
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.36
Shares outstanding108.60M
Short interest14.56% of float
Earnings dateAug 6, 2026 (est.)
Analyst target52.62
Profit margin0.00%

Against its peers

Compare in full ›
EWTX SLDB CYTK IONS PTCT DSGN
Market cap 4.18B 719.48M 8.73B 7.26B 5.25B 682.77M
P/E (TTM) — — — — — —
Forward P/E -21.2 -3.9 -14.1 -39.3 26.5 -6.7
Price/book 9.2 1.9 -50.2 16.4 -31.7 3.4
Dividend yield — — — — — —
1-year change +161.56% +7.70% +2.88% −38.81% −4.80% +64.80%
Today −1.56% −2.33% −0.19% −3.56% −2.75% −6.35%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All EWTX news ›
MarketScreener·Positive

Transcript : Edgewise Therapeutics, Inc. - Special Call

Presentation Operator MessageOperator Hello, and welcome to the Edgewise Therapeutics Update Call. [Operator Instructions] As a reminder, this conference is being recorded today. If you have any... Transcript : Edgewise Therapeutics, Inc.…

MarketScreener·

Edgewise Therapeutics, Inc. : Insider Transactions

Follow insider transactions on Edgewise Therapeutics, Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Edgewise Therapeutics, Inc. Biotechnology & Medical Research…

MarketScreener·

All Transcripts on Edgewise Therapeutics, Inc. (EWTX)

Find all the latest transcripts on Edgewise Therapeutics, Inc. Transcripts Edgewise Therapeutics, Inc. Biotechnology & Medical Research All financial news and data tailored to specific country editions

MarketScreener·

All Transcripts on Egetis Therapeutics AB (EGTX)

Find all the latest transcripts on Egetis Therapeutics AB Transcripts Egetis Therapeutics AB Biotechnology & Medical Research All financial news and data tailored to specific country editions

MarketScreener·Positive

Edgewise's EDG-7500 Mechanism Lends Confidence, RBC Says

Edgewise Therapeutics' EDG-7500 mechanism reveal accounts for strong clinical showing, lending confidence ahead of phase 3 trial design, RBC said in a Tuesday note. Earlier, the company unveiled... Biotechnology & Medical Research…

From articles in the 4Search news index.

In the news

15mentions in 30 days
12with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 15 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.